Benzimidazoles and analogues and their use as protein kinases inhibitors

Details for Australian Patent Application No. 2002334217 (hide)

Owner Aventis Pharmaceuticals Inc

Inventors Morley, Andrew David; Babin, Didier; Reader, John C; Amendola, Shelley; Cherry, Michael; Gardner, Charles J; Majid, Tahir Nedeem; Cox, Paul, Joseph; Gillespy, Timothy Alan; Khan, Nawaz M; Le Brun, Alain; Deprets, Stephanie Daniele; Pedgrift, Brian; Edwards, Michael Louis; Payne, Lloyd J; Gauzy, Laurence; Edlin, Christopher David; Bouchard, Herve

Agent Watermark

Pub. Number AU-B-2002334217

PCT Number PCT/GB02/04763

PCT Pub. Number WO2003/035065

Priority 0206893.0 22.03.02 GB; 01/13868 26.10.01 FR; 60/395,060 11.07.02 US; 0206895.5 22.03.02 GB; 60/395,151 11.07.02 US

Filing date 24 October 2002

Wipo publication date 6 May 2003

Acceptance publication date 3 July 2008

International Classifications

A61K 31/4184 (2006.01)

A61K 31/4188 (2006.01)

A61K 31/42 (2006.01) - Oxazoles

A61K 31/437 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/454 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 31/5377 (2006.01)

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/02 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/10 Drugs for skeletal disorders

Event Publications

13 February 2003 Complete Application Filed

  Priority application(s): 0206893.0 22.03.02 GB; 01/13868 26.10.01 FR; 60/395,060 11.07.02 US; 0206895.5 22.03.02 GB; 60/395,151 11.07.02 US

3 July 2003 Application Open to Public Inspection

  Published as AU-B-2002334217

3 July 2008 Application Accepted

  Published as AU-B-2002334217

30 October 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002334218-PROCESS FOR REDUCING IMMUNOGENIC REACTIONS USING SELECTIVE TH1 CELL BINDING ANTIBODIES

2002334216-GAS TREATMENT APPARATUS